Sinuclean's Treatment Of Sinusitis' Symptoms

Summary

The goal of the study is to demonstrate that SINUclean DM® spray, added to the standard (amoxicillin/clavulanate) therapy of the acute episode of sinusitis (acute, subacute or chronic), is safe ad capable to determine the resolution of the symptoms in a shorter time in comparison with the standard therapy without co-adjuvant, or with simple saline lavage.

Timeline

Start

2007-11

Primary completion

2009-01

Completion

2010-02

Outcome

Met primary endpoint

registry NUMBER Control: 71 percentage of patients NUMBER Saline Treated.: 57 percentage of patients NUMBER Sinuclean Treated.: 33 percentage of patients NCT00747747 ↗

registry analysis (superiority or other test); Control vs Saline Treated. vs Sinuclean Treated.; p <0.05; Frequency 0; Chi-squared NCT00747747 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sinuclean DM Spray	Unknown	—	Intranasal

Indications